Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Astrazeneca ADR buy MoneyMoney

Start price
€50.60
27.11.21 / 0%
Target price
€60.00
27.11.22
Performance (%)
26.48%
End price
€64.00
28.11.22
Summary
This prediction ended on 28.11.22 with a price of €64.00. The BUY prediction by MoneyMoney finished with a performance of 26.48%. A total of €0.43 was paid as dividends for this prediction. This prediction was marked as speculative and is excluded from MoneyMoney's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Astrazeneca ADR 4.098% 4.098% -0.470%
iShares Core DAX® 2.149% 5.415% 21.385%
iShares Nasdaq 100 0.838% 1.926% 44.386%
iShares Nikkei 225® 1.143% 2.887% 27.641%
iShares S&P 500 1.265% 3.698% 33.327%

According to MoneyMoney what are the pros and cons of Astrazeneca ADR for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons
Significant cyclical dependencies

Comments by MoneyMoney for this prediction

In the thread Astrazeneca ADR diskutieren
Prediction Buy
Perf. (%) 26.48%
Target price 60.000
Change
Ends at 27.11.22

Buy mit Kursziel 60,0

In the thread Trading Astrazeneca ADR
Prediction Buy
Perf. (%) 26.48%
Target price 60.000
Change
Ends at 27.11.22

Die von MoneyMoney gewählte maximale Laufzeit wurde überschritten